This year should combine both commercial opportunities and regulatory risks for private equity. Deal multiples are high and will probably stabilize or continue to go a little higher given the combined effect of a scarcity of...more
2/12/2021
/ Coronavirus/COVID-19 ,
Economic Downturn ,
Fund Sponsors ,
Investment Opportunities ,
Investors ,
Popular ,
Portfolio Companies ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Risk Assessment
On July 29, President Obama signed the National Bioengineered Food Disclosure Standard (S. 764) into federal law. This law will establish national standards for the labeling of food containing genetically engineered (“GE”)...more